SMMT
Summit Therapeutics PLC
18.00$
+3.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q1 18 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q1 19 | Q2 19 | Q3 19 | Q1 20 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | +174.9% | -30.5% | +61.6% | +0.0% | +834.7% | -98.3% | +21.3% | +375.8% | -95.0% | -50.7% | -2.0% | +116.5% | -34.8% | -19.3% | +2.2% | -3.6% | +3.0% | -70.4% | +2,257.4% | -80.9% | +2.5% | +1.4% | +2.0% | -99.6% | -100.0% | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -65.2% | +3,881.0% | -105.0% | – | -2,572.1% | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | -37.1% | +25.6% | +27.2% | +1.0% | -95.5% | -25.9% | 0.0% | +74,603.7% | -99.8% | +48.0% | – | – | +910.3% | – | – | |
| – | +0.0% | +174.9% | -30.5% | +61.6% | +0.0% | +834.7% | -98.3% | +0.0% | +477.0% | +1,006.6% | -99.8% | -2.0% | +116.5% | -34.8% | -19.3% | +2.2% | -3.6% | +3.0% | -70.4% | +2,257.4% | -80.9% | +2.5% | +1.4% | +2.0% | -402.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +5.1% | +31.2% | +12.4% | +54.7% | +34.9% | -36.5% | +5.8% | -12.2% | -4.9% | -4.8% | +7.1% | -8.7% | +28.3% | +10.5% | -4.6% | -2.9% | -10.2% | +39.6% | +29.7% | -14.4% | +15.5% | -8.4% | -52.7% | +106.3% | -70.8% | +9,557.0% | -98.3% | +68.8% | +55.0% | +25.7% | +48.1% | -22.1% | +45.5% | -3.3% | +230.4% | +0.0% | +12.4% | -10.0% | +18.9% | – | |
| – | -13.5% | +2.2% | -20.4% | +61.8% | +14.6% | -16.8% | +93.7% | -40.6% | -32.6% | -30.1% | +1.6% | +29.7% | +31.7% | +84.4% | -12.1% | +13.9% | -58.1% | +36.6% | +42.5% | -2.9% | +36.9% | -11.9% | +12.4% | -12.4% | +25.6% | -10.3% | -11.6% | -10.4% | +103.9% | +0.5% | +19.7% | +39.6% | -24.4% | +4.6% | +754.7% | +0.0% | -24.8% | -19.3% | +0.3% | – | |
| – | -4.5% | +21.8% | -6.6% | +60.9% | +5.4% | +22.7% | -28.0% | -5.6% | -8.1% | -54.3% | +7.4% | -5.1% | +50.8% | +99.9% | -19.4% | +5.9% | -35.3% | +44.6% | +38.5% | -10.3% | +26.0% | -12.3% | -37.7% | +44.7% | +9.3% | +2,493.0% | -97.1% | +35.1% | +69.1% | +18.3% | +40.4% | -7.4% | +20.0% | -1.3% | +352.6% | +0.0% | -4.0% | -13.2% | +13.0% | – | |
| – | – | – | – | – | – | – | -136.9% | – | -180.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.8% | -0.6% | +3.3% | -7.4% | -6.0% | -23.9% | -61.3% | +1.0% | +2.4% | -22.7% | +23.6% | +7.8% | -35.9% | +5.6% | -19.8% | +842.8% | -28.7% | +90.4% | -61.8% | -47.7% | +831.0% | -85.6% | +329.6% | +6.0% | +319.7% | +186.7% | -69.8% | +8.2% | +6.4% | +7.7% | -0.6% | -20.9% | -99.6% | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -133.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -188.5% | – | – | -351.2% | – | – | – | – | – | -51.0% | -531.8% | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | -779.5% | – | – | -105.1% | – | -90.9% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -138.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -142.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.